Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital marketplace for direct investment in institutional-quality commercial real estate for accredited and institutional investors.
Cadre is a New York-based real estate investment platform that provides accredited investors and institutions with access to direct investments in commercial real estate assets — multifamily apartments, office buildings, and industrial properties — that were previously accessible only to institutional investors with large minimum commitments. Cadre uses proprietary data science to source, underwrite, and manage real estate investments, and offers investors both individual property investments and a diversified portfolio product. The platform's secondary market allows investors to sell their positions before a property is liquidated, providing liquidity typically unavailable in private real estate investments. Cadre was founded in 2014 by Ryan Williams and early team members from Goldman Sachs and Blackstone, with backing from investors including Andreessen Horowitz, Goldman Sachs, and General Catalyst. The platform has managed over $5B in transaction volume and has distributed significant returns to investors. It competes with Fundrise, CrowdStreet, and RealtyMogul in the digital real estate investment platform market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.